Author

H. Meltzer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:Drosophila· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

A. K. Tryba· 1 shared A. P. Sergeeva· 1 shared A. U. Ahmed· 1 shared B. Bornstein· 1 shared B. Honig· 1 shared C. D. James· 1 shared C. Park· 1 shared D. S. Lopez· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Tryba

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cis inhibition of co-expressed DIPs and Dprs shapes neural development

N. C. Morano, D. S. Lopez, H. Meltzer, A. P. Sergeeva, P. S. Katsamba, K. D. Rostam, H. P. Gupta, J. E. Becker, B. Bornstein, F. Cosmanescu, O. Schuldiner, B. Honig, R. S. Mann, L. Shapiro

The paper shows that DIPs and Dprs interact in cis within the same cells, regulating trans interactions and influencing neural development in Drosophila.

PLOS Biology · Mar 3, 2025Peer-reviewedBiochemistry

Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastoma

S. P. Caragher, J. M. Shireman, M. Huang, J. Miska, S. Baisiwala, C. Park, M. Saathoff, L. Warnke, T. Xiao, M. S. Lesniak, C. D. James, H. Meltzer, A. K. Tryba, A. U. Ahmed

This paper shows that dopamine receptor 2 activation in glioblastoma cells increases their growth, stemness, and metabolic activity, suggesting dopamine signaling as a therapeutic target.

bioRxiv · Nov 16, 2018Cancer Biology